Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection

Owens, Jr., Robert C., Donskey, Curtis J., Gaynes, Robert P., Loo, Vivian G., Muto, Carlene A.·2008·Clinical Infectious Diseases

Cited by (603)

Items 401–500 of 603

  1. Fulminant Clostridium difficile toxic megacolon in a pediatric heart transplant recipient
    Angira Patel, Jeffrey G. Gossett, Tara Benton, Erin E. Rowell, Hyde M. Russell, Elaine M. Cham, Elfriede Pahl · 2010 · Pediatric Transplantation
  2. Inpatient antibiotic consumption in a regional secondary hospital in N ew Z ealand
    Chris Hopkins · 2014 · Internal Medicine Journal
  3. Approach to Antimicrobial Prophylaxis for Urology Procedures in the Era of Increasing Fluoroquinolone Resistance
    Elizabeth Marino Sabo, John J. Stern · 2014 · Annals of Pharmacotherapy
  4. Modeling Clostridium difficile in a hospital setting: control and admissions of colonized and symptomatic patients
    Farida Chamchod, Prasit Palittapongarnpim · 2019 · Theoretical Biology and Medical Modelling
  5. Incidence Of Clostridium difficile Infection And Associated Risk Factors Among Hospitalized Children In Qatar
    Ahmed Khalil, Mohamed A. Hendaus, Emad Bashier Ibrahim Elmagboul, Asmaa Sabry Abdrabou Mohamed, Anand Deshmukh, Ahmed Elmasoudi · 2019 · Therapeutics and Clinical Risk Management
  6. Does over a century of aerobic phage work provide a solid framework for the study of phages in the gut?
    Hiba Shareefdeen, Alexander P. Hynes · 2021 · Anaerobe
  7. Glutamatergic Agents for the Treatment of Cocaine Use Disorder
    Hasti Hadizadeh, José M. Flores, Talia F. Mayerson, Patrick D. Worhunsky, Marc Nicholas Potenza, Gustavo A. Angarita · 2022 · Current Behavioral Neuroscience Reports
  8. Microbiota intestinal: sus repercusiones clínicas en el cuerpo humano
    Norberto Gigliotti · 2013 · Archivos Argentinos de Pediatria
  9. The clinical impact of a urinary tract infection management bundle in a tertiary-care teaching hospital
    Timothy MacLaggan, Christopher P. Le, Kristen A. Iverson, Chelsey Ellis, Jacques Allard, Tammie J. Wilcox-Carrier, Daniel J. Smyth · 2018 · Infection Control and Hospital Epidemiology
  10. Improving utilization of antimicrobial drugs among physician assistants in the ED
    Dmitry Kiyatkin, Scott Mitchell Wright, Jonathan Mark Zenilman, Flora Kisuule · 2011 · JAAPA
  11. Current epidemiology and treatment ofClostridium difficileinfection
    Hyunjoo Pai · 2010 · Infection and Chemotherapy
  12. Regional differences inClostridium difficileinfections in relation to fluoroquinolone and proton pump inhibitor use, Finland, 2008–2011
    Mari J. Kanerva, Jukka P. Ollgren, Tinna Voipio, Silja Mentula, Outi Lyytikäinen · 2015 · Scandinavian Journal of Infectious Diseases
  13. Proton‐pump inhibitors and the risk of Clostridium difficile–associated diarrhea in high‐risk antibiotics users: A population‐based case‐crossover study
    Sung‐Hyun Hong, Eui‐Kyung Lee, Ju‐Young Shin · 2019 · Pharmacoepidemiology and Drug Safety
  14. The emergence of multidrug-resistant and hypervirulent Clostridium difficile clinical isolates
    Nada Khazal Kadhim Hindi, Zainab Hamood Alsaadi, Aalaa Fahim Abbas, Aamal Ghazi Mahdi Al-Saadi · 2019 · Meta Gene
  15. Oral Clindamycin Compared With Sequential Intravenous and Oral Flucloxacillin in the Treatment of Cellulitis in Adults
    Mark G. Thomas · 2014 · Infectious Diseases in Clinical Practice
  16. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli
    Benjamin J. Ereshefsky, Majdi N. Al‐Hasan, Yevgeniya Gokun, Craig A. Martin · 2016 · Journal of Chemotherapy
  17. Clostridium difficile and Laparoscopic Bariatric Surgery: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Database
    ThucNhi Tran Dang, Jerry T. Dang, Muhammad Moolla, Noah Jacob Switzer, Karen Madsen, Daniel W. Birch, Shahzeer Karmali · 2019 · Obesity Surgery
  18. Clostridium difficile Enterocolitis in a Captive Geoffroy’s Spider Monkey ( Ateles geoffroyi ) and Common Marmosets ( Callithrix jacchus )
    Alexandra R. Armstrong, Arno Wünschmann, Lora Heather Rigatti, Edwin C. Klein · 2019 · Veterinary Pathology
  19. Molecular epidemiology of Clostridium difficile strains from nosocomial-acquired infections
    Silvia Corbellini, Giorgio Piccinelli, Maria Antonia De Francesco, Giuseppe Ravizzola, Carlo Bonfanti · 2013 · Folia Microbiologica
  20. Clostridium difficile postantibiotic diarrhoea diagnosis.
    Syed Ali Haider Naqvi, Faisal F. Chaudhry · 2012 · PubMed
  21. Macrolides, Clindamycin, and Ketolides
    Sumathi Sivapalasingam, Neal H. Steigbigel · 2010 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  22. Recurrent Clostridioides difficile Infections
    Joffrey van Prehn, Ed J. Kuijper, Erik R. Dubberke · 2025 · JAMA
  23. Characterization of Food Chain Clostridioides difficile Isolates in Terms of Ribotype and Antimicrobial Resistance
    Pilar Marcos, Aoife Doyle, Paul Whyte, Thomas Richard Rogers, M. McElroy, Séamus Fanning, Jesús M. Frías, Declan Bolton · 2023 · Microorganisms
  24. Days of antibiotic spectrum coverage (DASC) as predictors of recurrent Clostridioides difficile infection: A retrospective cohort study
    Nobuaki Mori, Yuichi Shibata, Jun Hirai, Nobuhiro Asai, Hiroshige Mikamo · 2025 · Journal of Infection and Chemotherapy
  25. The tipping point: patients predisposed to Clostridium difficile infection and a hospital antimicrobial stewardship programme
    Shana D. Stites, Clarissa Cooblall, J. Aronovitz, S. Brook Singletary, K. Micklow, M. Sjeime · 2016 · Journal of Hospital Infection
  26. Laboratory Tests for the Diagnosis of Clostridium difficile Infections
    Romney M. Humphries · 2012 · Clinical Microbiology Newsletter
  27. Antimicrobial Stewardship: Considerations for a Cancer Center
    Coralia N. Mihu, Alla Paskovaty, Susan K. Seo · 2011 · Humana Press eBooks
  28. Antibiotic Stewardship am Beispiel der Staphylococcus aureus Bakteriämie
    Sebastian Weis, Aurelia Kimmig, Stefan Hagel, Mathias Wilhelm Pletz · 2017 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
  29. Antimicrobial Treatment of Infective Endocarditis, Caused by Enterococcus Faecalis
    Е. В. Ших, Т. Е. Морозова, Vladimir N. Drozdov, Natalia B. Lazareva, Шацкий Дмитрий Андреевич, Т. Б. Андрущишина, М. В. Лукина, О. А. Вартанова · 2019 · Rational Pharmacotherapy in Cardiology
  30. Audit of antibiotic duration of therapy, appropriateness and outcome in patients with nosocomial pneumonia following the removal of an automatic stop-date policy
    J. Do, Sandra A N Walker, S. E. Walker, W. Cornish, Andrew E. Simor · 2012 · European Journal of Clinical Microbiology & Infectious Diseases
  31. Prevention of Clostridium difficile Infection in Critically Ill Adults
    David D. Leedahl, Heather A. Personett, Avish Nagpal, Erin Frazee Barreto · 2018 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  32. Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes
    Clyde D. Ford, Bert K. Lopansri, Jana Coombs, Brandon J. Webb, Andy Nguyen, Julie D. Asch, Daanish Hoda · 2019 · Clinical Transplantation
  33. The potential of probiotic fermented milk products in reducing risk of antibiotic‐associated diarrhoea and Clostridium difficile disease
    Jonathan Lewis, Linda Valerie Thomas, William Weir · 2009 · International Journal of Dairy Technology
  34. Use of Data Envelopment Analysis to Quantify Opportunities for Antibacterial Targets for Reduction of Health Care–AssociatedClostridium difficileInfection
    Amy L. Pakyz, Yaşar A. Özcan · 2013 · American Journal of Medical Quality
  35. Patients With Nonanaphylactic Penicillin Allergy Are Not at Increased Risk of Allergic Events After Receiving Prophylactic Preoperative Cefazolin Prior to Closed Fracture Repair
    Gregory J. Della Rocca, Boris Mraović, James P. Stannard, Brett D. Crist, Kyle M. Schweser · 2025 · Clinical Orthopaedics and Related Research
  36. Prophylactic Vancomycin in the Primary Prevention of Clostridium difficile in Allogeneic Stem Cell Transplant
    Brendon Fusco, Jasmine Tomita‐Barber, Natale Mazzaferro, Anne Tyno, Nicole McEntee, Patricia J. Greenberg, ROGER K. STRAIR, Dale G. Schaar, DENNIS L. COOPER · 2025 · Transplant Infectious Disease
  37. Clinical prediction rule for identifying older patients with toxigenic clostridioides difficile at the time of hospital admission
    Ki-Byung Lee, Min A Lee, Jin Woong Suh, Kyung‐Sook Yang, Youseung Chung, Jeong Yeon Kim, Sun Bean Kim, Jang Wook Sohn, Young Kyung Yoon · 2023 · BMC Geriatrics
  38. Natural History of Clostridioides difficile–Related Disease Progression in the 2-Step Testing Era
    Nicholas Turner, Steven C. Grambow, Christopher R. Polage, David T. Kuhar, Preeta Krishnan Kutty, Rebekah W. Moehring, Deverick John Anderson · 2025 · Clinical Infectious Diseases
  39. Early-life antibiotic exposures: Paving the pathway for dysbiosis-induced disorders
    Ali Attiq · 2025 · European Journal of Pharmacology
  40. Acute laryngotracheitis after accidental aspiration of clindamycin
    Alessandro Ceschi, Margot von Dechend, Martín Krause, Marc Kengelbacher, Andreas Stuerer · 2010 · QJM
  41. Prevalence of inappropriate antibiotic prescriptions after the great east Japan earthquake, 2011
    Kentaro Iwata, Takahiko Fukuchi, Midori Hirai, Kenichi Yoshimura, Yasuhiro Kanatani · 2017 · Medicine
  42. The effect of rapid diagnostic testing with Infectious Diseases fellow consultative intervention on the management of enterococcal bloodstream infection
    Megan E. Gray, Heather L. Cox, Lindsay E Donohue, Melinda D. Poulter, Joshua C. Eby, Amy J. Mathers · 2018 · Diagnostic Microbiology and Infectious Disease
  43. Comparison of Fluoroquinolone Versus Non-Fluoroquinolone Therapy for Inpatient Treatment of Chronic Obstructive Pulmonary Disease Exacerbations
    Kassandra Ramos, Bryan Allen, Chad Cannon, Kristal Cunningham, Calvin Tucker · 2019 · Journal of Pharmacy Technology
  44. Clostridium difficile Infection in Western Romania: Correlations Between Ribotype and Clinical Form One year observational retrospective study
    Adelina Raluca Marinescu, Voichița Elena Lăzureanu, Ruxandra Laza, Virgil Musta, Narcisa Nicolescu, Monica Licker · 2019 · Revista de Chimie
  45. Nosokomiale Infektionen: Herausforderung MRSA und CDAD
    Winfried V. Kern, Markus Dettenkofer · 2009 · Der Internist
  46. Clostridium
    Indranil Samanta, Samiran Bandyopadhyay · 2019 · Elsevier eBooks
  47. Long-Term Implications of Antibiotic Use on Gut Health and Microbiota in Populations Including Patients With Cystic Fibrosis
    Jennifer Deane, Mary C. Rea, Fiona Fouhy, Catherine Stanton, R. Paul Ross, Barry J. Plant · 2016 · Elsevier eBooks
  48. Vaccines in development for the primary prevention of Clostridium difficile infection
    Laurel M. Legenza, Susanne G. Barnett, Warren E. Rose · 2017 · Journal of the American Pharmacists Association
  49. Factors related to antibiotic-associated diarrhea in patients in the intensive care unit receiving antifungals: a single-center retrospective study
    Jingjing Sun, Zhang Yanshu, Yu Liu, Shi Qindong, Xue Wang, Zhang Lei, Yingli He, Litao Guo · 2019 · Journal of International Medical Research
  50. Antibiotikaeinsatz beim akuten Durchfall des Hundes – Übersicht potenzieller Risiken, Indikationen und Alternativen
    Melanie Werner, Stefan Unterer · 2021 · Tierärztliche Praxis Ausgabe K Kleintiere / Heimtiere
  51. Clostridium difficile
    Tim Planche, Amber Arnold · 2009 · Medicine
  52. Clostridium Difficile–Associated Diarrhea in a Tertiary Care Medical Center
    Marilee D. Obritsch, Jeffrey S. Stroup, Ryan M. Carnahan, David N. Scheck · 2010 · Baylor University Medical Center Proceedings
  53. Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection
    Philip Chung, Brian P. Currie, Yi Guo, Moshe Talansky, Shakara Brown, Belinda E. Ostrowsky · 2014 · American Journal of Infection Control
  54. Clostridium difficileinfection: still principally a disease of the elderly
    Naomi G. Diggs, Christina M. Surawicz · 2010 · Therapy
  55. Mathematical Modeling of the Effects of Nutrient Competition and Bile Acid Metabolism by the Gut Microbiota on Colonization Resistance Against Clostridium difficile
    Arietta E. Fleming-Davies, Sara Jabbari, Suzanne L. Robertson, Tri Sri Noor Asih, Cristina Lanzas, Suzanne Lenhart, Casey M. Theriot · 2017 · Association for Women in Mathematics series
  56. Consumption of Antibiotics and Epidemiology of Clostridioides difficile in the European Union in 2016—Opportunity for Practical Application of Aggregate ECDC Data
    Estera Jachowicz-Matczak, Anna Różańska, Monika Pobiega, Mariusz Topolski, Jadwiga Wójkowska‐Mach · 2020 · Antibiotics
  57. Preventing Health Care-Associated Infection: Development of a Clinical Prediction Rule for Clostridium difficile Infection.
    Greta L. Krapohl · 2011 · Deep Blue (University of Michigan)
  58. Commonly prescribed drugs as risk factors for Clostridioides difficile infections: a Swedish population-based case–control study
    Annelies Boven, Harry Vranken, Erika Vlieghe, Annemarie Boleij, Katja Fall, Lars G. Engstrand, Nele Brusselaers · 2026 · Gut
  59. Do antimicrobial stewardship programme interventions reduce the rate of and protect against Clostridium difficile infection?
    Bih Yee Chia, Jocelyn Qi-Min Teo, Winnie Lee, Yi Xin Liew, Pui Lai Rachel Ee, Maciej Piotr Chlebicki, Lynette Lin Ean Oon, Andrea Lay‐Hoon Kwa · 2019 · Journal of Global Antimicrobial Resistance
  60. Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Sicherheit und Verträglichkeit
    Ralf Stahlmann, Hartmut M Lode · 2020 · PubMed Central
  61. The Association Between the Frequency of Interruptions in Antibiotic Exposure and the Risk of Health Care-Associated Clostridiodes difficile Infection
    Jiyoun Song, Bevin Cohen, Jianfang Liu, Elaine Larson, Philip Zachariah · 2020 · Current Therapeutic Research
  62. A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany
    Florian Jakobs, Sebastian Marcel Wingen-Heimann, Julia Jeck, Anna Kron, Oliver A. Cornely, Florian Kron · 2021 · BMC Health Services Research
  63. Susceptibility testing of Escherichia coli isolates from urines: are we at risk of reporting false antibiotic resistance to co-amoxiclav?
    A. Bond, H. Plumb, P. Turner · 2012 · Journal of Antimicrobial Chemotherapy
  64. Rasch analysis of the Antimicrobial Self-Assessment Toolkit for National Health Service (NHS) Trusts (ASAT v17)
    Chantelle Bailey, Mary Patricia Tully, María Pampaka, Jonathan Cooke · 2016 · Journal of Antimicrobial Chemotherapy
  65. Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study
    Ali Elbeddini, Rachel Gerochi · 2021 · Journal of Pharmaceutical Policy and Practice
  66. Prevalence and Risk Factors of Clostridium difficile Infection Among Patients Hospitalized for a Flare of Inflammatory Bowel Disease in King Abdulaziz University Hospital
    Areej A Samman, Mona Alfares, Raghad A Bajabur, Roaa O Alnefaie, Lama S Alwadai, Weaam W Murad, Bayan M Dahal · 2023 · Cureus
  67. “Primum, non nocere”: The Epidemiology of Toxigenic Clostridioides difficile Strains in the Antibiotic Era—Insights from a Prospective Study at a Regional Infectious Diseases Hospital in Eastern Europe
    Lidia Oana Stămăteanu, Claudia Elena Plesca, Ionela-Larisa Miftode, Aida Corina Bădescu, Carmen Doina Manciuc, Mihnea Eudoxiu Hurmuzache, Florin Manuel Roşu, Radu-Ştefan Miftode, Maria Obreja, Egidia Gabriela Miftode · 2024 · Antibiotics
  68. Impact of type 2 diabetes mellitus on mortality and recurrence of clostridioides difficile infection
    Cristina Martinez-Cuevas, M. Nájera, Jessica Abadía Otero, Miriam Gabella Martín, Mónica de Frutos, José María Eirós Bouza, Luís Corral-Gudino, José Pablo Miramontes‐González · 2024 · Hospital Practice
  69. Severe Clostridium diffi cile infection after liver and kidney transplantation
    Kseniya Yu. Kokina, Yu. O. Malinovskaya, A. B. Sidorenko, Ya. G. Moisyuk · 2019 · Transplantologiya The Russian Journal of Transplantation
  70. A Retrospective Analysis of Risk Factors and Therapeutic Outcomes for Clostridium difficile Infection
    Patrick J Netland, Stephanie M. Brochardt, Ji M. Koo, Tze Shien Lo, Tammy Krenz · 2011 · Hospital Pharmacy
  71. Effect of Concomitant Antibiotics on Treatment of Clostridium difficile (CDI) Infection with Fidaxomicin or Vancomycin
    Kathleen M. Mullane · 2009 · 47th Annual Meeting
  72. Clostridium difficile
    Tim Planche · 2013 · Medicine
  73. Bezlotoxumab
    Danial E. Baker · 2017 · Hospital Pharmacy
  74. Treatment of Staphylococcal Infections
    Kent Crossley, Joseph F. John · 2009 · Wiley eBooks
  75. Is Fidaxomicin the Drug of Choice for Treating Clostridium difficile–Associated Diarrhea in Patients With Cancer?
    Myke R. Green, Utkarsh H. Acharya, Andrew M. Yeager · 2013 · Journal of Clinical Oncology
  76. Predominance of FQR1 NAP1/RT027 Clostridioides difficile Among Mexican Children and Adult Patients, and its Resistance to Eleven Antibiotics
    Emmanuel Aguilar-Zamora, César Rodríguez, Javier Torres, Nayeli Xochiquetzal Ortiz-Olvera, Gerardo Aparicio‐Ozores, Lourdes Flores‐Luna, Carlos Quesada-Gómez, Margarita Camorlinga‐Ponce · 2025 · Archives of Medical Research
  77. Antibiotic and Nonantibiotic Drugs Associated With Clostridioides difficile Infection Risk: a Pharmacopoeia-Wide Case-Cohort Study
    Kevin A Brown, Bryan A. Coburn, Alejandro Hernández, Bradley J. Langford, Valerie Leung, Derek R. MacFadden, Ashley M. Rooney, Kevin L. Schwartz, Nick Daneman · 2026 · The Journal of Infectious Diseases
  78. Clostridium difficile-Associated Colitis: Role of the Immune Response and Approach to Treatment
    Katie Solomon, Lorraine Kyne · 2012 · InTech eBooks
  79. Contribution of C lostridium difficileinfection to the development of lower gastrointestinal adverse events during autologous stem cell transplantation
    Senu K. Apewokin, Julia A. Goodwin, J.Y. Lee, Stephen W. Erickson, Naveen Sanathkumar, Vinay R. Raj, Daohong Zhou, Kent D. McKelvey, Owen Stephens, Elizabeth Ann Coleman · 2015 · Transplant Infectious Disease
  80. Clostridium difficile as a Risk Associated with Animal Sources
    M. Ellin Doyle · 2013
  81. Clostridium difficile Colonization Before and After Hospitalization in Children
    Turkay Rzayev, Pelin Yüksel Mayda, Tülay Erkan, Bekir Sami Kocazeybek, Tufan Kutlu · 2021 · Turkish Archives of Pediatrics
  82. The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study
    Sandrine Couture, Charles H. Frenette, Ian Schiller, Rowin Alfaro, Nandini Dendukuri, Daniel J. G. Thirion, Yves Longtin, Vivian G. Loo · 2024 · Antimicrobial Stewardship & Healthcare Epidemiology
  83. Protective Effects of Huo Xiang Zheng Qi Liquid on Clostridioides difficile Infection on C57BL/6 Mice
    Ming Chen, Lin Zhai, Kristian Schønning, Warner Alpízar‐Alpízar, Ole Larum, Leif Percival Andersen, Susanne Holck, Alice Friis‐Møller · 2024 · Microorganisms
  84. Clinical significance of a positive Clostridioides difficile glutamate dehydrogenase test on the outcomes of hospitalized older patients
    Yohsuke Nagayoshi, Kazuko Yamamoto, Shuntaro Sato, Naofumi Suyama, Takuya Izumikawa, Kinichi Izumikawa, Taiga Miyazaki, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae · 2020 · Geriatrics and gerontology international/Geriatrics & gerontology international
  85. Preeclampsia de inicio temprano y tar dío: una antigua enfermedad, nuevas ideas
    Rommel Omar Lacunza Paredes, José Pacheco Romero · 2015 · Revista Peruana de Ginecología y Obstetricia
  86. Hypervirulent Clostridium difficile strains: Adherence, toxin production and sporulation
    Michelle M. Merrigan · 2010 · Loyola eCommons (Loyola University of Chicago)
  87. Clostridium difficile Infection: Current and Emerging Therapeutics
    Angie M. Jarrad, Mark A. T. Blaskovich, Dena Lyras, Matthew A. Cooper · 2015 · Current treatment options in infectious diseases/Current treatment options in infectious disease
  88. Overview ofClostridium difficileInfection as an Emerging Health Care Facility–Acquired Infection
    Vaneet Arora, Dhara N. Shah, Kevin W. Garey · 2013 · Hospital Pharmacy
  89. Clostridium difficile Outbreak: A Small Group of Pharmacists Makes a Big Impact
    Donna Bower, Frances Hachborn, Patricia Huffam · 2009 · The Canadian Journal of Hospital Pharmacy
  90. Analysis of Clinical Characteristics and Risk Factors to Neurosurgical Patients withClostridium Difficile-Associated Diarrhea
    Yong‐Sang Kim, Hong Jun Jeon, Su-A Nam, Byung Moon Cho, Se-Hyuck Park, Se Moon Oh · 2011 · Journal of Korean Neurotraumatology Society
  91. Stronger correlation between antibiotic use and the incidence of Clostridium difficile determined by culture results instead of faecal toxin detection only
    Dominik Mertz, Reno Frei, Herbert Plagge, Manuel Battegay, Andreas Franz Widmer · 2010 · European Journal of Clinical Microbiology & Infectious Diseases
  92. Interaction of Age and Levofloxacin Exposure on the Incidence of Clostridium difficile Infection
    Nathan D. Mah, John W. Ahern, Carolyn J. Terhune, W. Kemper Alston · 2011 · Infectious Diseases in Clinical Practice
  93. Purulent Skin and Soft Tissue Infection
    Steven Alexander Kahn, Erika Venniro, Ryan J. Beers, Christopher W. Lentz · 2010 · Journal of Primary Care & Community Health
  94. Recurrencias en infecciones por Clostridium difficile en pacientes con cáncer
    Tomás García‐Lozano, Eduardo Aznar-Oroval, Salvador Martín-Utrilla · 2016 · Medicina Clínica
  95. Community-acquired Clostridium difficile infections in emergency departments
    D. Lefevre-Tantet-Etchebarne, Valérie Sivadon‐Tardy, Benjamin Davido, Frédérique Bouchand, Julie Grenet, Éric Farfour, R. Getti, Clara Duran, Mireille Cheron, Emmanuel Mathieu et al. · 2016 · Médecine et Maladies Infectieuses
  96. Infections in the Immunocompromised Patient
    Yoshiro Hayashi, David L. Paterson · 2011 · Elsevier eBooks
  97. Clostridium-difficile-Infektion bei geriatrischen Patienten
    R. Simmerlein, A. Basta, Markus Gosch · 2016 · Zeitschrift für Gerontologie und Geriatrie
  98. Comparison of the rates of C lostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation
    Karin Koseck, Amir S. Steinberg, Gina Caliendo, Joanne Meyer, Sara S. Kim · 2017 · Transplant Infectious Disease
  99. Prevention and Treatment of Clostridium difficile Enterocolitis
    Lisa M. Kodadek, Pamela A. Lipsett · 2018 · Advances in Surgery
  100. Food-borne diarrheal illness
    Christopher P. Conlon · 2010 · Elsevier eBooks